1bsk: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1bsk.gif|left|200px]] | [[Image:1bsk.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_1bsk", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_1bsk| PDB=1bsk | SCENE= }} | ||
}} | |||
'''ZINC DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI''' | '''ZINC DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI''' | ||
| Line 32: | Line 29: | ||
[[Category: Pei, D.]] | [[Category: Pei, D.]] | ||
[[Category: Rajagopalan, P T.]] | [[Category: Rajagopalan, P T.]] | ||
[[Category: | [[Category: Deformylase]] | ||
[[Category: | [[Category: Inhibitor]] | ||
[[Category: | [[Category: Metalloproteinase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 11:54:22 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
Revision as of 11:54, 2 May 2008
ZINC DEFORMYLASE INHIBITOR COMPLEX FROM E.COLI
OverviewOverview
While protein synthesis in bacteria begins with a formylated methionine, the formyl group of the nascent polypeptide is removed by peptide deformylase. Since eukaryotic protein synthesis does not involve formylation and deformylation at the N-terminus, there has been increasing interest in peptide deformylase as a potential target for antibacterial chemotherapy. Toward this end and to aid in the design of effective antibiotics targeting peptide deformylase, the structures of the protein-inhibitor complexes of both the cobalt and the zinc containing Escherichia coli peptide deformylase bound to the transition-state analogue, (S)-2-O-(H-phosphonoxy)-L-caproyl-L-leucyl-p-nitroanilide (PCLNA), have been determined. The proteins for both deformylase-inhibitor complexes show basically the same fold as for the native enzyme. The PCLNA inhibitor adopts an extended conformation and fits nicely into a hydrophobic cavity located near the metal site. On the basis of these structures, guidelines for the design of high-affinity deformylase inhibitors are suggested. As our results show that the protein residues which interact with the PCLNA inhibitor are conserved over a wide variety of species, we suggest that antibiotics targeting deformylase could have wide applicability.
About this StructureAbout this Structure
1BSK is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
ReferenceReference
Structural basis for the design of antibiotics targeting peptide deformylase., Hao B, Gong W, Rajagopalan PT, Zhou Y, Pei D, Chan MK, Biochemistry. 1999 Apr 13;38(15):4712-9. PMID:10200158 Page seeded by OCA on Fri May 2 11:54:22 2008